Invention Grant
- Patent Title: VEGF-binding fusion proteins and therapeutic uses thereof
- Patent Title (中): VEGF结合融合蛋白及其治疗用途
-
Application No.: US12623869Application Date: 2009-11-23
-
Publication No.: US07972598B2Publication Date: 2011-07-05
- Inventor: Thomas J. Daly , James P. Fandl , Nicholas J. Papadopoulos
- Applicant: Thomas J. Daly , James P. Fandl , Nicholas J. Papadopoulos
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agent Valeta Gregg; Frank R. Cottingham
- Main IPC: A61K38/18
- IPC: A61K38/18 ; C07K14/71
Abstract:
Fusion proteins which bind and inhibit vascular endothelial growth factor (VEGF). The VEGF-binding fusion proteins are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
Public/Granted literature
- US20100087632A1 VEGF-Binding Fusion Proteins and Therapeutic Uses Thereof Public/Granted day:2010-04-08
Information query
IPC分类:
